Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep 29;6(3):147-161.
doi: 10.1556/1886.2016.00029.

Insights from 100 Years of Research with Probiotic E. Coli

Trudy M Wassenaar  1
Affiliations
Review

Insights from 100 Years of Research with Probiotic E. Coli

Trudy M Wassenaar. Eur J Microbiol Immunol (Bp). .

Abstract

A century ago, Alfred Nissle discovered that intentional intake of particular strains of Escherichia coli could treat patients suffering from infectious diseases. Since then, one of these strains became the most frequently used probiotic E. coli in research and was applied to a variety of human conditions. Here, properties of that E. coli Nissle 1917 strain are compared with other commercially available E. coli probiotic strains, with emphasis on their human applications. A literature search formed the basis of a summary of research findings reported for the probiotics Mutaflor, Symbioflor 2, and Colinfant. The closest relatives of the strains in these products are presented, and their genetic content, including the presence of virulence, genes is discussed. A similarity to pathogenic strains causing urinary tract infections is noticeable. Historic trends in research of probiotics treatment for particular human conditions are identified. The future of probiotic E. coli may lay in what Alfred Nissle originally discovered: to treat gastrointestinal infections, which nowadays are often caused by antibiotic-resistant pathogens.

Keywords: Escherichia coli; Nissle; Symbioflor; applications; human studies; probiotics.

PubMed Disclaimer

Conflict of interest statement

The author works as a consultant for SymbioPharm GmbH.

Figures

Fig. 1.
Fig. 1.
Trends in publication frequency over time for four keywords combined with “probiotics”
See this image and copyright information in PMC

References

    1. Kaas RS, Friis C, Ussery DW, Aarestrup FM: Estimating variation within the genes and inferring the phylogeny of 186 sequenced diverse Escherichia coli genomes. BMC Genomics 13, 577 (2012) - PMC - PubMed
    1. Tannock GW. (1995). Normal Microflora. An Introduction to Microbes Inhabiting the Human Body, Chapman and Hall, London, UK
    1. Caugant DA, Levin BR, Selander RK: Genetic diversity and temporal variation in the E. coli population of a human host. Genetics 98, 467–490 (1981) - PMC - PubMed
    1. Sender R, Fuchs S, Milo R: Revised estimates for the number of human and bacteria cells in the body. Plos Biol 14(8), e1002533 (2016) - PMC - PubMed
    1. Hill MJ, Drasar BS: The normal colonic bacterial flora. Gut 16, 318–323 (1975) - PMC - PubMed